Cyclic AMP (cAMP) confers drug resistance against DNA damaging agents via PKAIA in CML cells.
Eur J Pharmacol
; 794: 201-208, 2017 Jan 05.
Article
in En
| MEDLINE
| ID: mdl-27894809
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
DNA Damage
/
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Cyclic AMP
/
Drug Resistance, Neoplasm
/
Cyclic AMP-Dependent Protein Kinase Type I
Limits:
Humans
Language:
En
Journal:
Eur J Pharmacol
Year:
2017
Document type:
Article
Affiliation country: